| |
|
|
|
Products
Nuclear Cardiology
Brain PET
Support
Downloads
About Us
|
|
|
1.888.263.4446
|
|
|
We're Here For You
|
|
Click here for support
|
|
|
| |
|
| |
|
|
|
|
| |
|
About Us / The Executive Team
|
|
Meet the Executive Team at Syntermed.
|
| |
|
Syntermed has a seasoned executive team that has the right balance of experience in the medical and software field.
|
| |
| |
|
Michael Lee
|
| |
|
Chairman and CEO
|
|
As chairman and chief executive officer for Syntermed, Lee is part of the executive team which oversees Syntermed’s product and business strategy as well as the company's daily operations including business development, finances, sales, marketing, professional services and administration. Lee is also a member of Syntermed’s Board of Directors. With over 23 years of technology and leadership experience, Lee has a strong track record in building teams for marketing, sales, business development, software engineering and has managed all phases of the software business. Most recently, Lee served as Vice President for Sales and Business Development, eMarketing for Mobular Technologies where he was part of a team which secured a round of Series A funding. Prior to joining Mobular, Lee was National Sales Director for Commercial Software Products for MessageMedia, Inc. (SoftBank portfolio company and recently acquired by DoubleClick), where he managed a team which grew revenue 300% in just one year. Lee joined Messagemedia when it acquired Revnet Systems, Inc, an early leader in the Internet direct e-mail marketing software segment. Earlier, Lee spent several years at Georgia Tech. First as Director of Sales and Marketing for the Computer-Aided Structural Engineering Center at the Georgia Institute of Technology where he also spent several years developing large scale engineering software solutions, and then later as Manager of Intellectual Property Marketing for the Georgia Tech Research Corporation where he worked with the Advanced Technology Development Center and other Atlanta entrepreneurs to transfer technology from Georgia Tech to the commercial sector. Lee earned both a Masters and Bachelors degree in Structural Engineering with Highest Honor from Georgia Tech and is a member of the Technology Association of Georgia, the Atlanta CEO forum, a past director of the Atlanta chapter of the American Lung Association, a charter member of the Atlanta Peachtree Rotary Club, and a director for two private Atlanta area companies.
|
| |
| |
|
Ken Van Train
|
| |
|
President
|
B.S.- Biology 1972, Loyola Marymount University M.S. - Computer Science 1996, Azusa Pacific University Mr. Van Train has worked in the field of computer science and medical imaging since 1977. He previously worked as the Director of Computer Research & Development in the Department of Medical Physics and Imaging at Cedars-Sinai Medical Center where he had been employed from 1979 - 2003.
In addition, he served 15 years as the president of NucCardiac Software, Inc., a medical device software company, and currently serves as the regulatory affairs officer for Areeda Associates, Ltd.. His research work at Cedars-Sinai Medical Center has been involved with the development, validation, and commercialization of 4 medical software products which are distributed worldwide: Cedars Planar Quantitative Tl-201, Cedars Quantitative SPECT TL-201, Cedars-Emory CEqual®, and the Emory Cardiac Toolbox. Mr. Van Train has authored or co-authored 77 manuscripts and book chapters and 152 abstracts in the field of nuclear medicine and image processing. He has served as Co-investigator of multiple NIH and commercial research grants. His FDA medical device regulatory experience has been obtained over the past 17 years as part of the process of software commercialization.
He has been responsible for registering 3 medical device companies with the FDA. These companies have resulted in the submission of 19 premarket notification 510(k)’s which have all been accepted by the FDA. Formation of the companies has also involved the establishment and maintenance of a Quality System Plan (formally know as Good Manufacturing Practices) within the 3 medical device companies in order to comply with FDA medical device regulations.
|
| |
| |
|
Ernest V. Garcia, Ph.D.
|
| |
|
Chief Scientific Advisor
|
|
B.S. 1971, M.S., 1972, Ph.D. 1974, University of Miami Dr. Garcia joined Emory University in 1985 after 12 years of experience in medical imaging obtained at the University of Miami, Florida and at Cedars-Sinai Medical Center/UCLA in Los Angeles. He is currently Professor of Radiology at Emory and a full time researcher. From 1997-2005 He was Vice-chairman of Research for the Department of Radiology at Emory University. From 1993-2000, he was Director of the Emory Center for PET, and the Advanced Imaging Research Center. From 1990-1993, he was the Co-Director of the Emory/Georgia Tech Biomedical Technology Research Center. Dr. Garcia's research interest lies in the areas of medical imaging and bioinformatics. His main area of development has been in the field of quantitative analysis of cardiac images. His techniques have resulted in six commercial products used worldwide for quantifying myocardial perfusion images. He also developed the first computer interface for the real time acquisition and display of 2D-echo images. Dr. Garcia has authored or co-authored over 213 articles, 49 chapters and 7 books in the fields of nuclear medicine, cardiovascular imaging and image processing. He is a member of the editorial boards of the Journal of Nuclear Medicine, the Journal of Nuclear Cardiology, the International Journal of Cardiovascular Imaging, the European Journal of Nuclear Medicine and Molecular Imaging, the Journal of Nuclear Medicine Communications, and Revista Espanola de Medicina Nuclear. He is a past board member of the Society of Nuclear Medicine, the American Society of Nuclear Cardiology, and the Institute for Clinical PET. Dr. Garcia is a past President of the Cardiovascular Council of the Society of Nuclear Medicine, the 1996/97 President of the Institute for Clinical PET (now part of the Academy for Molecular Imaging), the 2002-03 President of the American Society for Nuclear Cardiology and the 2003-04 Founding President of the American Society for Nuclear Cardiology Foundation. In 2006 he was selected by the readers of Medical Imaging Magazine as a Medical Imaging Industry Top 10 Nuclear Medicine Researcher of 2005. At the National Institutes of Health, Dr. Garcia was a member of the Diagnostic Radiology Study Section from 1986-1990. At the Food and Drug Administration, he served on the Radiopharmaceutical Drugs Advisory Committee from 1990-1994.
|
|
| |
|
| |
|
|
SPOTLIGHT
|
|
|
University research sparks economic growth
|
|
|
Syntermed Launches NeuroQ 3.5 at ICAD 2010
|
|
|
Limited time offer to purchase Dr. Silverman's book
|
|
|
|
| |
|